Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein microarrays: molecular profiling technologies for clinical specimens.

Virginia Espina1, Arpita I Mehta, Mary E Winters

  • 1FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute/NIH, Building 10 Room B1B53, 9000 Rockville Pike, Bethesda, MD 20892, USA. espinav@mail.nih.gov

Proteomics
|November 5, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vertical inhibition of the autophagy pathway impairs growth and enhances sensitivity to mTORC1 inhibition in pancreatic ductal adenocarcinoma.

bioRxiv : the preprint server for biology·2026
Same author

Acquisition of resistance to RAS inhibition is associated with the upregulation of macropinocytosis through both PI3K-dependent and -independent signaling.

Cancer research communications·2026
Same author

Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.

JCO precision oncology·2026
Same author

CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor-stromal signaling.

Cell death & disease·2026
Same author

Laser capture microdissection.

Nature reviews. Methods primers·2026
Same author

Immunoproteomic insights into inflammatory diseases of the critically endangered black rhinoceros (Diceros bicornis).

Scientific reports·2026

Proteomics, the study of protein function, enhances cancer understanding. Protein microarrays offer molecular therapy insights for personalized cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Proteomics, the study of protein function, is crucial for understanding cancer pathogenesis.
  • Integrating proteomics with transcript profiling may lead to personalized molecular therapies for neoplasms.
  • Protein microarrays are an emerging proteomic technology with broad applications in discovery and quantitative analysis.

Purpose of the Study:

  • To explore the utility of protein microarrays in understanding cancer pathogenesis.
  • To highlight the role of protein microarrays in identifying molecular targets for personalized cancer therapy.
  • To discuss the challenges and advancements in protein microarray technology for clinical applications.

Main Methods:

  • Utilizing protein microarrays, including Reverse Phase Arrays, for proteomic analysis.

Related Experiment Videos

  • Analyzing post-translational modifications of proteins to reflect signal pathway and network activity.
  • Applying protein microarrays to cellular samples for signal network profiling.

    • Main Results:

    • Protein microarrays provide insights into protein function and activity states within biological systems.
    • The technology enables gathering information on post-translational modifications, crucial for understanding cellular signaling.
    • Reverse Phase Arrays are optimized for tissue specimens, facilitating analysis of biopsy samples.

    Conclusions:

    • Proteomics, particularly through protein microarrays, significantly advances our understanding of cancer pathogenesis.
    • Protein microarrays are key to developing personalized molecular therapies tailored to individual neoplasms.
    • Advancements in protein microarray design and application, such as Reverse Phase Arrays, address analytical challenges and support clinical trial research.